Korea Kyungjin Peter Kim, CEO of ST Pharm, provides an insight into his expansion of the company’s operations from simply a CMO into a CDMO and new drug development. He also explains his decision to focus on manufacturing oligonucleotides, the potential in that market, and the challenges to the next objectives.…
Yungjin The CEO of Yungjin, a leading Korean pharma company, talks about the revitalization of the company he has overseen since being appointed in 2010. To begin, could you please introduce yourself, and Yungjin? Yungjin has a long history; it is one of the oldest pharmaceutical companies in Korea, having…
See our Cookie Privacy Policy Here